Welcome to our dedicated page for Ufp Technologies SEC filings (Ticker: UFPT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
UFP Technologies Inc. filings document operating results and material events for its medical-device contract development and manufacturing business. Form 8-K reports furnish quarterly and annual earnings releases, non-GAAP financial measures, Regulation FD investor presentation materials, material definitive agreements with strategic medical customers, cybersecurity incident disclosures, and executive succession and compensation arrangements.
Proxy filings cover board elections, executive compensation, equity awards, pay-versus-performance disclosure, and shareholder voting matters. These records frame the company's governance, capital and incentive structure, customer-contract disclosures, and public reporting obligations as a Nasdaq-listed operating company.
UFP Technologies director Cynthia L. Feldmann reported an exercise-and-sell transaction in common stock. She exercised stock options to acquire 1,200 shares at $43.95 per share, then executed open-market sales totaling 1,200 shares at prices around $239–$240 per share. These transactions reflect portfolio rebalancing while maintaining a direct share position in the company.
UFP Technologies reported several leadership and compensation changes. The company appointed Ryan Stafford as General Counsel, Senior Vice President of Human Resources, and Secretary effective June 4, 2026, succeeding retiring executive Chris Litterio. Stafford joins with extensive public-company legal, HR, and M&A experience from Littelfuse and Tyco.
The Board also appointed Mitchell C. Rock as Chief Executive Officer and expanded the Board from seven to eight members, naming Rock to fill the new directorship. Under his offer letter, Stafford will receive a $400,000 base salary and a 2026 cash bonus opportunity targeted at 50% of salary, subject to performance.
The Compensation Committee approved equity awards under the 2003 Incentive Plan. Stafford received an annual equity grant valued at $650,000, split equally between restricted stock units (RSUs) and performance share awards. RSUs granted include 2,895 units for CEO Rock, 4,454 units for CFO Ronald J. Lataille, and 1,448 units for Stafford, generally vesting in thirds on March 1 of 2027, 2028, and 2029, except for Lataille’s separate schedule. Lataille’s 4,454 stock units represent $1 million, vesting 50% on June 5, 2028 and 50% on March 30, 2029, with continued vesting protection in certain termination scenarios.
Stafford’s performance share awards provide a target of 1,448 shares and a maximum of 2,896 shares based on operating income and return-on-invested-capital objectives, with determination expected in February 2029 and issuance on March 1, 2029, subject to employment and plan terms, including change-in-control provisions.
UFP Technologies Executive Chairman Jeffrey R. Bailly reported routine equity compensation activity. He received a grant of 1,787 shares of common stock at no cost, while 750 shares were disposed of to cover tax obligations through share withholding. Following these transactions, he directly holds 171,950 shares of UFP Technologies common stock. A footnote states he also holds 28,706 shares indirectly through a trust and disclaims beneficial ownership of those shares beyond any pecuniary interest.
Stafford Ryan K reported acquisition or exercise transactions in this Form 4 filing.
UFP Technologies granted Senior Vice President of Human Resources Ryan K. Stafford 1,448 stock unit awards on June 4, 2026 under the company’s 2003 Incentive Plan. These units are settled solely in common stock and vest in three equal installments on March 1 of 2027, 2028, and 2029, contingent on continued employment.
UFP Technologies Inc. executive Ryan K Stafford, SVP Human Resources, filed an initial Form 3 reporting his ownership in the company. The filing shows he holds no shares of the company’s Common Stock, $.01 par value, as his direct position following this report.
UFP Technologies, Inc. furnished updated investor presentation materials outlining its business, markets and financial profile. The company reports 2025 revenue of $603 million, up from $179 million in 2020, representing 3.4× revenue growth over that period.
For 2025, UFP cites a 28.6% gross margin and 17.1% adjusted operating margin, positioning itself within a large and growing global medical device market estimated at about $518 billion. Management targets 12–18% annual revenue growth, 28–31% gross margins and 17–20% adjusted operating margins over the next 3–5 years, and highlights a $1.7 billion market capitalization, non-GAAP metrics, and a strategy focused on high-margin MedTech segments and customer-centric acquisitions.
LATAILLE RONALD J reported acquisition or exercise transactions in this Form 4 filing.
UFP Technologies’ Chief Financial Officer Ronald J. Lataille received an equity award of 4,454 stock units of common stock. The grant was made on June 4, 2026 at no cash purchase price under the company’s 2003 Incentive Plan and is compensation-related, not an open-market purchase.
The units vest over time, with one-third vesting on March 1, 2027 and additional one-third portions vesting on March 1, 2028 and March 1, 2029, so long as he remains continuously employed through each date. After this award, he directly holds 20,352 shares and also owns 38,940 shares indirectly.
ROCK MITCHELL reported acquisition or exercise transactions in this Form 4 filing.
UFP Technologies President Mitchell Rock received a compensation-related stock grant. He was awarded 2,895 stock units of common stock at no cost under the company’s 2003 Incentive Plan. These stock units are to be settled solely in shares of common stock.
The grant vests over three years, with one-third vesting on March 1, 2027, and additional one-third portions vesting on March 1, 2028 and March 1, 2029, provided he remains continuously employed by the company through each vesting date. After this award, Rock directly holds 39,115 shares of common stock.
Hassett Joseph John reported acquisition or exercise transactions in this Form 4 filing.
UFP Technologies director Joseph John Hassett received an equity award of 802 restricted stock units (RSUs) that will settle in common shares. The grant, priced at $0.00 per share as a compensation award, was made under the company’s 2009 Non-Employee Director Stock Incentive Plan.
The RSUs vest 100% on May 31, 2027, provided he continues to serve as a director through that date. After this grant, Hassett has direct ownership of 2,425 shares of common stock, including the awarded RSUs.